NCT02085304 Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM Status TERMINATED Phase PHASE1/PHASE2
NCT02065466 Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases Status WITHDRAWN Phase PHASE1/PHASE2
NCT02052648 Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02049593 PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02046187 Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT02044120 ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma Status COMPLETED Phase PHASE1
NCT02029573 Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma Status COMPLETED Phase PHASE2
NCT02025881 Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT02023905 Everolimus With and Without Temozolomide in Adult Low Grade Glioma Status TERMINATED Phase PHASE2
NCT02015728 Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors Status UNKNOWN Phase NA
NCT01991977 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy Status COMPLETED Phase PHASE2
NCT01985451 Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL) Status UNKNOWN Phase PHASE2
NCT01985087 A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01977677 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT01957956 Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT01946529 Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors Status COMPLETED Phase PHASE2
NCT01907165 Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide Status COMPLETED Phase EARLY_PHASE1
NCT01900951 Temozolomide as Maintenance Therapy in Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT01891747 A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma Status COMPLETED Phase PHASE1